Assessing para-aortic nodal status in high-grade endometrial cancer patients with negative pelvic sentinel lymph node biopsy
View abstract on PubMed
Summary
This summary is machine-generated.Pelvic sentinel lymph node biopsy (SLN) may miss para-aortic (PA) node metastases in high-grade uterine cancers. Patients with negative pelvic SLNs and no chemotherapy had a 14.7% distant recurrence rate.
Area Of Science
- Gynecologic Oncology
- Surgical Pathology
- Cancer Staging
Background
- High-grade endometrial cancers present unique staging and treatment challenges.
- Accurate detection of lymph node metastasis is crucial for guiding adjuvant therapy decisions.
Purpose Of The Study
- To evaluate the accuracy of pelvic sentinel lymph node biopsy (SLN) in identifying positive para-aortic (PA) lymph nodes in high-grade uterine cancer.
- To assess recurrence rates in patients with high-grade uterine cancers who did not receive adjuvant chemotherapy following negative pelvic SLNs.
Main Methods
- Retrospective cohort study of 110 patients with high-grade endometrial cancer undergoing surgery with pelvic SLN biopsy.
- Analysis included demographics, surgical management, pathology data, and outcomes via descriptive statistics and survival analysis.
Main Results
- 5.8% of patients had positive PA nodes despite negative pelvic SLNs.
- Among 75 patients with negative pelvic SLNs and no adjuvant chemotherapy, the distant recurrence rate was 14.7% with a 3-year recurrence-free survival of 71.9%.
Conclusions
- The rate of isolated PA node metastasis in high-grade endometrial cancer with negative pelvic SLNs may be higher than previously accepted.
- Adjuvant treatment decisions should continue to integrate primary tumor pathology and molecular classification.

